Angiopoietin-1 and Angiopoietin-2 Expression Imbalance Influence in Early Period After Subarachnoid Hemorrhage.
	    		
		   		
		   			
		   		
	    	
    	- Author:
	        		
		        		
		        		
			        		Hua GU
			        		
			        		
			        		
			        			1
			        			,
			        		
			        			2
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Zhen Hai FEI
			        		
			        		;
		        		
		        		
		        		
			        		Yi Qi WANG
			        		
			        		;
		        		
		        		
		        		
			        		Jian Guo YANG
			        		
			        		;
		        		
		        		
		        		
			        		Chao Hui ZHAO
			        		
			        		;
		        		
		        		
		        		
			        		Yong CAI
			        		
			        		;
		        		
		        		
		        		
			        		Xing Ming ZHONG
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Original Article
 - Keywords: Angiopoietin-1; Angiopoietin-2; Subarachnoid Hemorrhage; Blood-Brain Barrier; Brain Injuries
 - MeSH: Angiopoietin-1*; Angiopoietin-2*; Animals; Blood-Brain Barrier; Blotting, Western; Brain; Brain Injuries; Capillary Permeability; Evans Blue; Hippocampus; Immunohistochemistry; Microvessels; Permeability; Punctures; Rats; Subarachnoid Hemorrhage*
 - From:International Neurourology Journal 2016;20(4):288-295
 - CountryRepublic of Korea
 - Language:English
 - Abstract: PURPOSE: Microvascular endothelial integrity is important for maintaining the blood-brain barrier (BBB). However, subarachnoid hemorrhage (SAH) disrupts this integrity, making the BBB dysfunctional—an important pathophysiological change after SAH. Angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) regulate microvascular permeability by balancing each other’s expression. METHODS: This study investigated the dynamics of Ang-1 and Ang-2 expression after SAH and the protective effect of Ang-1 on BBB functioning using an endovascular puncture model of rat SAH. The Ang-1 and Ang-2 expression in brain tissue was determined by immunohistochemistry. In addition, Western blotting was used to estimate Ang-1 and Ang-2 concentration and to compare them at 6–72 hours post-SAH cortex and hippocampus. Evans blue viability assay was used to evaluate BBB permeability, and neurological testing was implemented to evaluate neurological impairment during SAH. RESULTS: It was found that following SAH, Ang-1 expression decreases and Ang-2 expression increases in the cortex, hippocampus, and microvessels. The Ang-1/Ang-2 ratio decreased as quickly as 6 hours after SAH and reached its lowest 1 day after SAH. Finally, it was found that exogenous Ang-1 reduces SAH-associated BBB leakage and improves neurological function in post-SAH rats. CONCLUSIONS: Our findings suggest that the equilibrium between Ang-1 and Ang-2 is broken in a period shortly after SAH, and the treatment of exogenous Ang-1 injection alleviates neurological dysfunctions through decreasing BBB destruction.
 
            